Advertisement
Home »

GLP-1-Based Therapy for Diabetes Confers No Increased IBD Risk

Mar 14, 2023

REFERENCES & ADDITIONAL READING

Christensen HS.  GLP-1 based therapies and risk of Inflammatory Bowel Disease: real world evidence from a nationwide cohort study. DOP57, ECCO 2023, 01–04 March, Copenhagen, Denmark.

ABOUT THE CONTRIBUTORS

Author

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement